AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. Its product candidates, DSUVIA (also known as DZUVEO) and ZALVISO, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings.